Works matching DE "HEPATITIS A virus cellular receptors"
Results: 246
Interaction of the Immune System TIM-3 Protein with a Model Cellular Membrane Containing Phosphatidyl-Serine Lipids.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 22, p. 1, doi. 10.1002/chem.202304318
- By:
- Publication type:
- Article
A Novel Subtype of Acquired Generalized Lipodystrophy Associated With Subcutaneous Panniculitis-Like T-cell Lymphoma.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 5, p. 1, doi. 10.1210/jcemcr/luae069
- By:
- Publication type:
- Article
Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity.
- Published in:
- Science Immunology, 2024, v. 9, n. 101, p. 1, doi. 10.1126/sciimmunol.adp7302
- By:
- Publication type:
- Article
Beyond T cell exhaustion: TIM-3 regulation of myeloid cells.
- Published in:
- Science Immunology, 2024, v. 9, n. 93, p. 1, doi. 10.1126/sciimmunol.adf2223
- By:
- Publication type:
- Article
β-Catenin in Dendritic Cells Negatively Regulates CD8 T Cell Immune Responses through the Immune Checkpoint Molecule Tim-3.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 460, doi. 10.3390/vaccines12050460
- By:
- Publication type:
- Article
肾透明细胞癌中免疫检查点相关的免疫逃逸机制的研究进展.
- Published in:
- Progress in Modern Biomedicine, 2022, v. 22, n. 4, p. 796, doi. 10.13241/j.cnki.pmb.2022.04.041
- By:
- Publication type:
- Article
Matrix Metalloproteinases in Health and Disease in the Times of COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
The rise of TIM‐3: A promising immune target in diffuse midline gliomas.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1536
- By:
- Publication type:
- Article
Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1069696
- By:
- Publication type:
- Article
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1<sup>-</sup> stem cell-like T cells over PD-1<sup>+</sup> T cells curbing tumor progression.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1113858
- By:
- Publication type:
- Article
Cutting edges and therapeutic opportunities on tumorassociated macrophages in lung cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1007812
- By:
- Publication type:
- Article
Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.903419
- By:
- Publication type:
- Article
Early detection of soluble CD27, BTLA, and TIM-3 predicts the development of nosocomial infection in pediatric burn patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.940835
- By:
- Publication type:
- Article
Diagnostic and Predictive Values of Ferroptosis-Related Genes in Child Sepsis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.881914
- By:
- Publication type:
- Article
Role of the PD-1/PD-L1 Pathway in Experimental Trypanosoma cruzi Infection and Potential Therapeutic Options.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.866120
- By:
- Publication type:
- Article
Increased Level of Tim-3<sup>+</sup>PD-1<sup>+</sup>CD4<sup>+</sup>T Cells With Altered Function Might Be Associated With Lower Extremity Arteriosclerosis Obliterans.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.871362
- By:
- Publication type:
- Article
Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.823842
- By:
- Publication type:
- Article
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0752-8
- By:
- Publication type:
- Article
TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 6, p. 1, doi. 10.1371/journal.pntd.0006983
- By:
- Publication type:
- Article
Retraction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis.
- Published in:
- 2024
- Publication type:
- Correction Notice
TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumors.
- Published in:
- PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0297695
- By:
- Publication type:
- Article
Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescents.
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-024-03438-w
- By:
- Publication type:
- Article
T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Gene Expression as a Negative Biomarker of B-Cell Acute Lymphoblastic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 11148, doi. 10.3390/ijms252011148
- By:
- Publication type:
- Article
The Putative Role of TIM-3 Variants in Polyendocrine Autoimmunity: Insights from a WES Investigation.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 10994, doi. 10.3390/ijms252010994
- By:
- Publication type:
- Article
Effects of PACAP Deficiency on Immune Dysfunction and Peyer's Patch Integrity in Adult Mice.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 19, p. 10676, doi. 10.3390/ijms251910676
- By:
- Publication type:
- Article
The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2042, doi. 10.3390/ijms24032042
- By:
- Publication type:
- Article
Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 1879, doi. 10.3390/ijms24031879
- By:
- Publication type:
- Article
miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810242
- By:
- Publication type:
- Article
Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival Outcome.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 3207, doi. 10.3390/ijms23063207
- By:
- Publication type:
- Article
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Allicin May Promote Reversal of T-Cell Dysfunction in Periodontitis via the PD-1 Pathway.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 17, p. 9162, doi. 10.3390/ijms22179162
- By:
- Publication type:
- Article
Expression Level and Significance of Tim-3 in CD4<sup>+</sup> T Lymphocytes in Peripheral Blood of Patients with Coronary Heart Disease.
- Published in:
- Brazilian Journal of Cardiovascular Surgery, 2022, v. 37, n. 3, p. 350, doi. 10.21470/1678-9741-2020-0509
- By:
- Publication type:
- Article
TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-09386-7
- By:
- Publication type:
- Article
Chronic non-bacterial osteomyelitis and immune checkpoint molecules.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 553, doi. 10.1007/s10067-023-06761-y
- By:
- Publication type:
- Article
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 515, doi. 10.1007/s00262-022-03264-8
- By:
- Publication type:
- Article
Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 1, p. 55, doi. 10.1007/s00262-022-03228-y
- By:
- Publication type:
- Article
Immune escape mechanism behind resistance to anti-PD-1 therapy in gastrointestinal tract metastasis in malignant melanoma patients with multiple metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 9, p. 2293, doi. 10.1007/s00262-022-03154-z
- By:
- Publication type:
- Article
Inhibitory Checkpoint Receptor TIM-3 as a Regulator of the Functional Activity of Dendritic Cells.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2024, v. 177, n. 3, p. 287, doi. 10.1007/s10517-024-06175-z
- By:
- Publication type:
- Article
Negative Regulation of RIG-I by Tim-3 Promotes H1N1 Infection.
- Published in:
- Immunological Investigations, 2023, v. 52, n. 1, p. 1, doi. 10.1080/08820139.2022.2113407
- By:
- Publication type:
- Article
The TIM-3 Rs10053538 Polymorphism Is Associated with Clinical Prognosis of Colorectal Cancer.
- Published in:
- Immunological Investigations, 2022, v. 51, n. 5, p. 1302, doi. 10.1080/08820139.2021.1936011
- By:
- Publication type:
- Article
Association between T-Cell Immunoglobulin and Mucin Domain 3 (TIM-3) Genetic Polymorphisms and Susceptibility to Autoimmune Diseases.
- Published in:
- Immunological Investigations, 2019, v. 48, n. 6, p. 563, doi. 10.1080/08820139.2019.1599009
- By:
- Publication type:
- Article
Prognostic Role of OX40, LAG-3, TIM-3 and PD-L1 Expression in Bone and Soft Tissue Sarcomas.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 12, p. 3620, doi. 10.3390/jcm13123620
- By:
- Publication type:
- Article
Soluble immune checkpoints are elevated in patients with primary biliary cholangitis.
- Published in:
- European Journal of Medical Research, 2023, v. 28, n. 1, p. 1, doi. 10.1186/s40001-023-01419-6
- By:
- Publication type:
- Article
RIPK3 modulates sarcoma through immune checkpoint HAVCR2.
- Published in:
- Oncology Letters, 2022, v. 24, n. 5, p. N.PAG, doi. 10.3892/ol.2022.13501
- By:
- Publication type:
- Article
Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13318
- By:
- Publication type:
- Article
Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13308
- By:
- Publication type:
- Article
H2AFZ Is a Prognostic Biomarker Correlated to TP53 Mutation and Immune Infiltration in Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.701736
- By:
- Publication type:
- Article
Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.763886
- By:
- Publication type:
- Article
TIM-3 in Leukemia; Immune Response and Beyond.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.753677
- By:
- Publication type:
- Article
Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.731175
- By:
- Publication type:
- Article